NFE2L2 and infectious otitis media: At week 16 post-AOM administration, the abundance of A. muciniphila in the male WT AOM/DSS-treated and Nrf2 KO AOM/DSS-treated groups was higher than that in the male WT control and male Nrf2 control groups (0.84%, 24.84%, 8.35%, and 39.13% in the male WT control, male WT AOM/DSS-treated, male Nrf2 KO control, and male Nrf2 KO AOM/DSS-treated groups, respectively) (p = 0.036 for male WT control vs. WT AOM/DSS-treated and p = 0.013 for male Nrf2 KO control vs. male Nrf2 KO AOM/DSS-treated) (Figures 6A, B).